Annexes to COM(2024)2 - EU position in the sixty-seventh session of the Commission on Narcotic Drugs on the scheduling of substances under the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, and the Convention on Psychotropic Substances of 1971

Please note

This page contains a limited version of this dossier in the EU Monitor.

Annex to the Framework Decision.
(7) With one single exception which has been referred to the Court of Justice.
(8) Judgment of the Court of Justice of 7 October 2014, Germany v Council, C-399/12, ECLI:EU:C:2014:2258, paragraph 64.
(9) Judgment of the Court of Justice of 7 October 2014, Germany v Council, C-399/12, ECLI:EU:C:2014:2258, paragraphs 61 to 64.
(10) Article 3(7) of the Convention on Narcotic Drugs; Article 2(7) of the Convention on Psychotropic Substances.
(11) United Nations Treaty Series, vol. 978, No. 14152.
(12) United Nations Treaty Series, vol. 1019, No. 14956.
(13) Council Framework Decision 2004/757/JHA of 25 October 2004 laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking (OJ L 335, 11.11.2004, p. 8).
(14) Austria, Belgium, France, Finland, Hungary, Italy, Lithuania, Malta, Netherlands, Poland, Portugal, Slovenia, and Spain.
(15) https://www.who.int/groups/who-expert-committee-on-drug-dependence/46th-ecdd-documents    
(16) Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December 2006 on the European Monitoring Centre for Drugs and Drug Addiction (OJ L 376, 27.12.2006, p. 1).
(17) Commission Delegated Directive (EU) 2022/1326 of 18 March 2022 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of new psychoactive substances in the definition of ‘drug’ (OJ L 200, 29.7.2022, p. 148).
Top


EUROPEAN COMMISSION

Brussels, 9.1.2024

COM(2024) 2 final


ANNEX

to the

Proposal for a Council Decision

on the position to be taken on behalf of the European Union in the sixty-seventh session of the Commission on Narcotic Drugs on the scheduling of substances under the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, and the Convention on Psychotropic Substances of 1971


ANNEX

Position to be taken by the Member States which are members of the Commission on Narcotic Drugs, acting jointly, in the interest of the Union during the sixty-seventh session of the Commission on Narcotic Drugs scheduled from 14 to 22 March 2024 regarding changes in the scope of control of substances:

(1)Bromazolam is to be included in Schedule IV of the Convention on Psychotropic Substances.

(2)Butonitazene is to be included in the Schedule I of the Convention on Narcotic Drugs.

(3)3-Chloromethcathinone (3-CMC) is to be included in Schedule II of the Convention on Psychotropic Substances.

(4)Dipentylone is to be included in Schedule II of the Convention on Psychotropic Substances.

(5)2-Fluorodeschloroketamine (2-FDCK) is to be included in Schedule II of the Convention on Psychotropic Substances.


Top
×
Timeline legend

Initial legal act

Another version

Selected version

Selected version application period

Hidden intermediate versions

Version which is applicable today

Future version
All